NCT07101159 2025-08-03
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Fujian Cancer Hospital
Phase 2 Not yet recruiting
Fujian Cancer Hospital
NHS Tayside
Instituto Nacional de Cancer, Brazil
Dharmais National Cancer Center Hospital
National Cancer Center, Korea
National Cancer Center, Korea